Zahir Soonawalla

Zahir Soonawalla

Auto-generated profile, based on publicly available information

Zahir Soonawalla

Department of HPB surgery, Oxford University Hospitals NHS Foundation Trust, Oxford OX3 7DQ, UK

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2004 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
TOT Orug
T Orug
ZSZ F Soonawalla
Z F Soonawalla
KTKoray Tekin
Koray Tekin
SOS P Olliff
S P Olliff
JBJ A C Buckels
J A C Buckels
AMA D Mayer
A D Mayer
Background: In the present era of liver transplantation and transjugular intrahepatic portosystemic shunts, the role and choice of shunt surgery for portal hypertension was reviewed. Methods: This retrospective study analysed the management of patients with portal hypertension in a tertiary liver transplant unit between June 1993 and May 2002. During this 9-year interval, 394 patients underwent endoscopic control of varices, 235 transjugular intrahepatic portosystemic shunts were inserted, 1142 liver transplants were performed, while only 29 patients needed a surgical portosystemic shunt. Results: Twenty-nine shunt operations were performed in nine patients with cirrhosis, one patient with congenital hepatic fibrosis and 19 without parenchymal liver disease. There were 12 side-to-side lienorenal, nine mesocaval, three proximal lienorenal, two distal lienorenal, two portacaval and one mesoportal shunts. Encephalopathy was seen in five of 11 patients with a non-selective shunt, but did not occur after side-to-side or selective lienorenal shunt procedures. At a median follow-up of 42·5 months, one mesocaval shunt had thrombosed and one portacaval shunt had stenosed; both were successfully managed by percutaneous intervention. To date, six patients have died; two succumbed to postoperative complications, one of which was related to the shunt. Conclusion: Patients with Budd–Chiari syndrome and cirrhosis can nearly always be managed by a combination of endoscopy, interventional radiology and liver transplantation. In the rare instances when these therapies fail in patients with cirrhosis, a side-to-side lienorenal shunt is a good option.

5 July 2024 in Science Advances
Verified
Journal Article
Open access
DHDaniel Llwyd Hughes
Daniel Llwyd Hughes
AEAlice Evans
Alice Evans
SGSimei Go
Simei Go
MEMichael Eyres
Michael Eyres
LPLiuliu Pan
Liuliu Pan
EOEric O'Neill
Eric O'Neill
Pancreatic ductal adenocarcinoma (PDAC) is the most common form of pancreatic cancer, a disease with dismal overall survival. Advances in treatment are hindered by a lack of preclinical models. Here, we show how a personalized organotypic “avatar” created from resected tissue allows spatial and temporal reporting on a complete in situ tumor microenvironment and mirrors clinical responses. Our perfusion culture method extends tumor slice viability, maintaining stable tumor content, metabolism, stromal composition, and immune cell populations for 12 days. Using multiplexed immunofluorescence and spatial transcriptomics, we identify immune neighborhoods and potential for immunotherapy. We used avatars to assess the impact of a preclinically validated metabolic therapy and show recovery of stromal and immune phenotypes and tumor redifferentiation. To determine clinical relevance, we monitored avatar response to gemcitabine treatment and identify a patient avatar-predictable response from clinical follow-up. Thus, avatars provide valuable information for syngeneic testing of therapeutics and a truly personalized therapeutic assessment platform for patients.

1 February 2000 in British Journal of Surgery
Verified
Journal Article
Open access
SMS K Mathur
S K Mathur
ZSZ F Soonawalla
Z F Soonawalla
SSShivam Shah
Shivam Shah
MGM Goel
M Goel
SSS Shikare
S Shikare
Background: Currently used predictors for bile duct calculi in patients undergoing cholecystectomy have low specificity resulting in unnecessary cholangiograms being performed. The role of biliary scintiscan in predicting the presence of bile duct calculi was assessed. Methods: Seventy-five patients with symptomatic gallstone disease were studied prospectively regarding the value of a history of jaundice or acute pancreatitis, raised serum bilirubin and serum alkaline phosphatase levels, and visualization of stones or presence of dilated bile ducts on ultrasonography (standard criteria) in detecting bile duct calculi. Results of biliary scintiscan were evaluated against a combination of standard criteria. The ‘gold standard’ for evaluation was endoscopic or peroperative cholangiography. Results: Biliary scintiscan had a higher sensitivity and specificity (93 and 94 per cent) than a combination of the above standard and modified predictors for biliary calculi (89 and 71 per cent). A combination of ultrasonography and selective use of scintiscan, in the absence of bile duct dilatation only, had higher values (96 and 98 per cent). Conclusion: A combination of ultrasonography and biliary scintiscan can accurately predict bile duct calculi and could be used as a guide for selective cholangiography.

1 January 2021 in HPB
Verified
Journal Article
Closed access
JBJ. Bergquist
J. Bergquist
ALA. Li
A. Li
Nikolaos ChatzizachariasNikolaos Chatzizacharias
Nikolaos Chatzizacharias
ZSZ. Soonawalla
Z. Soonawalla
PAP. Athanasopoulos
P. Athanasopoulos
BVB. Visser
B. Visser

1 January 2019 in HPB
Verified
Journal Article
Closed access
AMAlma Moekotte
Alma Moekotte
SLSanne Lof
Sanne Lof
SWSteven White
Steven White
RMRavi Marudanayagam
Ravi Marudanayagam
BABilal Al-Sarireh
Bilal Al-Sarireh
MHMo Abu Hilal
Mo Abu Hilal